Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 1;1(4):151-153.
doi: 10.5588/ijtldopen.24.0131. eCollection 2024 Apr.

A publicly accessible global data repository - the WHO TB-IPD platform

R L Goodall  1 , S M Fabiane  1 , A Hakiman  1 , A M Crook  1 , F Mirzayev  2 , S Schumacher  2 , M X Rangaka  1   3
Affiliations
Editorial

A publicly accessible global data repository - the WHO TB-IPD platform

R L Goodall et al. IJTLD Open. .
No abstract available

Keywords: data sharing; meta-analysis; treatment; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared.

Figures

Figure 1.
Figure 1.
The TB-IPD Platform. IPD = individual patient data.
Figure 2.
Figure 2.
Status of historical datasets in TB-IPD Platform. IPD = individual patient data.
See this image and copyright information in PMC

References

    1. Honeyborne I, et al. . The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world? Int J Infect Dis 2019;80:S23–28. - PubMed
    1. Ahuja SD, et al. . Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med 2012;9(8):e1001300. - PMC - PubMed
    1. Ahmad N, et al. .; Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet 2018;392(10150):821–834. - PMC - PubMed
    1. Morgan H, et al. . Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: a retrospective cohort study. Clin Infect Dis Clin Infect Dis. 2024. Mar 25:ciae145. - PMC - PubMed
    1. World Health Organization . Global individual patient data platform for drug-resistant tuberculosis treatment. Geneva, Switzerland: WHO, 2021.

Publication types

LinkOut - more resources